Oncology Research

Orally -Bioavailable Androgen Receptor Degrader, Potential Next-Generation Therapeutic for Enzalutamide-Resistant Prostate Cancer. Ponnusamy and Narayana et al

Jack Crawford2021-04-05T09:15:41+00:00

A 2019 Clinical Cancer Research Paper Review: Improving Preclinical Anticancer Studies Using Rat Xenograft Model Systems

Jack Crawford2022-10-07T08:35:25+00:00

HeraBioLabs | Ramesh Narayanan

Jack Crawford2023-03-01T07:26:07+00:00

HeraBioLabs | Goutham Narla

Jack Crawford2023-03-01T07:25:50+00:00

HeraBioLabs | Fallon Noto

Jack Crawford2023-03-01T07:26:47+00:00

Overcoming translational barriers by using the SRG Rat: case studies with the OncoRat®

Jack Crawford2023-03-01T07:27:23+00:00

The OncoRat – Three experts describe their experience

Jack Crawford2023-03-01T07:27:53+00:00

Fine Needle Aspirate Serial Tumor Sampling Services To Boost Your Xenograft Study Capabilities

Insightful Insights, Precision Toxicology and Efficacy News

Fine Needle Aspirate Serial Tumor Sampling Services To Boost Your Xenograft Study Capabilities

Xenograft tumors from human cancer cell lines in immunocompromised mice are [...]

Hera Admin2022-02-24T18:09:30+00:00

Validation Of The SRG Rat For Human Tumor Studies Published In PLOS ONE

Insightful Insights, Precision Toxicology and Efficacy News

Validation Of The SRG Rat For Human Tumor Studies Published In PLOS ONE

We Are Excited To Announce That A Validation Study Using [...]

Jack Crawford2022-02-15T22:17:52+00:00

786-O renal cell carcinoma tumor model

VALIDATED CELL LINE 786-O Renal Cell Carcinoma [...]

Hera Admin2024-11-02T16:48:35+00:00

Previous 678 Next

Title